Molecular Cytogenetics Market Set for Rapid Growth, to reach Value around USD 5.80 billion by 2030
Zion Market Research has published a new report titled “Molecular Cytogenetics Market by Product (instruments, consumables and software & services), Technique (Genomic In Situ Hybridization (GISH), Fluorescence In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Multicolor Fluorescence In Situ Hybridization, Array Comparative Genomic Hybridization and Other Molecular Cytogenetic Techniques), Application (Genetic Disorders, Oncology, Personalized Medicine and Other Applications), End user (Clinical & Research Laboratories, Hospitals & Pathology Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies and Other End-user): Global Industry Perspective, Comprehensive Analysis and Forecas.
According to the report, The molecular cytogenetic market which was USD 2.76 billion in 2022, is expected to reach USD 5.80 billion by 2030, at a CAGR of 9.7% during the forecast period 2023 to 2030
Molecular cytogenetics consists of molecular biology and cytogenetics. Cytogenetics refers to the study of chromosomes and also involves the analysis by in-situ hybridization techniques of genetic variations or modifications. Molecular cytogenetics finds important applications in the field of biology and medicine. Molecular cytogenetics is the genetic variation by in-situ hybridization techniques. This offers an overview of genome organization, behavior and structure that is high-resolution. The global Molecular Cytogenetics market is growing at a significant rate due to the increasing incidence of cancer and genetic disorders and the expanding penetration of Molecular Cytogenetics in clinical pathology research. Various products have contributed to the size of the Molecular Cytogenetics industry, such as kits & reagents, consumables, tools and technology & services.
Increasing incidence of cancer and the resulting rise in annual mortality has dramatically moved the market. Continued growth in new cancer cases has demonstrated the need for advanced technology for a detailed understanding of cancer at the genomic stage. FISH and Comparative Genomic Hybridization (CGH) are among the most widely recognized cytogenetic methods, offering comprehensive information on cancer-related molecular signatures. These methods help to gain insight into the cancer progression. Lack of consistent policies to cover and reimburse new genomic tools may impede the use of Molecular Cytogenetics in cancer and personalized treatment. However, in the future, the shortage of qualified workers and high costs associated with the implementation and handling of advanced techniques are likely to hamper the market.
The market for Molecular Cytogenetics is segmented based on product, application, technique, end user, and region. Based on product, the market is segmented into instruments, consumables and software & services. Throughout cytogenetic study, the increased use of media and reagents has rendered consumables the largest category. Consumables aid in both normal and advanced cytogenetic clinical procedures to produce reliable and reproducible outcomes.
Based on technique, the market is segmented into Genomic In Situ Hybridization (GISH), Fluorescence In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Multicolor Fluorescence In Situ Hybridization, Array Comparative Genomic Hybridization and Other Molecular Cytogenetic Techniques. In the current scenario, CGH and FISH techniques are widely adopted through different applications such as diagnostics, clinical practices, and medicine production. Based on application, the market is segmented into Genetic Disorders, Oncology, Personalized Medicine and Other Applications. Successful and high use of molecular cytogenetic techniques has enabled oncology to emerge as the largest category of application for in-depth cancer studies.
Based on end-user, the market is segmented into Clinical & Research Laboratories, Hospitals & Pathology Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies and Other End-user. The Clinical & Work Laboratories dominated the market in 2018. This is largely due to the increasing use of cytogenetic techniques in clinical diagnosis. Continuous work into the mechanisms underlying various chromosomal diseases has allowed the segment to gain the largest share.
The regional segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further classified into major countries such as US, Canada, Germany, UK, France, China, Japan, India, GCC countries, Brazil. Due to the local involvement of big companies, North America accounted for the largest share in 2018. In addition, the lack of an effective regulatory framework to control genetic testing has increased the regional market significantly.
Some of the players included in Molecular Cytogenetics market are -
- ARUP Laboratories
- Calgary Laboratory Services
- Genesis Laboratories Inc.
- Integrated Systems Engineering S.r.l.
- Neogenomics
- OHSU School of Medicine-Molecular and Medical Genetics
- South West Thames Regional Genetics Service
- UCLA Health — UCLA Pathology and Laboratory Medicines
- UW Cytogenetic Services
- Virtual Scientific
- Weill Cornell Medicine and WiCell Research Institute
The report segments global Molecular Cytogenetics market as follows:
Global Molecular Cytogenetics Market: Product Segment Analysis
- Instruments
- Consumables
- Software & Services
Global Molecular Cytogenetics Market: Technique Segment Analysis
- Genomic In Situ Hybridization (GISH)
- Fluorescence In Situ Hybridization (FISH)
- Comparative Genomic Hybridization (CGH)
- Multicolor Fluorescence In Situ Hybridization
- Array Comparative Genomic Hybridization
- Other Molecular Cytogenetic Techniques
Global Molecular Cytogenetics Market: Application Segment Analysis
- Genetic Disorders
- Oncology
- Personalized Medicine
- Other Applications
Global Molecular Cytogenetics Market: End-user Segment Analysis
- Clinical & Research Laboratories
- Hospitals & Pathology Laboratories
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Other End-user
Global Molecular Cytogenetics Market: Regional Segment Analysis
- North AmericaU.S.
- EuropeUKFranceGermany
- Asia PacificChinaJapanIndia
- Latin AmericaBrazil
- Middle East and Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us — after all — if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49–322 210 92714 USA/Canada Toll-Free №1–855–465–4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com